Sunovion Pharmaceuticals has submitted two supplemental new drug applications (sNDAs) to the FDA seeking approval for the use of LATUDA (lurasidone HCl) as monotherapy and adjunctive therapy in adult patients with depressive episodes ...
Tags: FDA, sNDA, atypical class of drugs, bipolar depression
NanoViricides, a development stage company, has reported effectiveness of an anti-influenza drug candidate, under FluCide program, when given orally. According to the information received from the contract laboratory that performed the ...
The Canadian Food Inspection Agency(CFIA)has announced the results of a study which revealed that most pre-packaged ground spice samples in Canada would not pose a risk to gluten-sensitive consumers. For the study,a total of 268 imported ...
Cytochroma, a clinical stage specialty pharmaceutical company, has selected OmniComm Systems' eClinical Suite of applications for its two Phase III studies. OmniComm's eClinical Suite, including the EDC, CTMS, Safety, and Coding ...
Tags: Cytochroma, clinical stage, eClinical Suite, patient data, adverse events
NSF International, which develops standards as well as tests and certifies products , has completed the acquisition of Becker & Associates Consulting. Becker & Associates, a clinical and scientific consulting firm, provides regulatory ...
Tags: certifies products, clinical consulting, scientific consulting
Boehringer Ingelheim and Funxional Therapeutics have signed an agreement under which Boehringer will acquire the global rights to Funxional's FX125L compound and somatotaxin program. Boehringer is responsible for all further research, ...
Aarti Industries, a manufacturer of chemicals and pharmaceuticals, has decided to merge the manufacturing division of Anushakti Chemicals and Drugs with it. Anushakti Chemicals is an associate company of Aarti with 49.67% stake, and is a ...
Tags: cooperation, chemical service, manufacturer
IDG News Service-The Russian legislature's lower house on Wednesday adopted a bill that,according to tech companies in the country,could lead to Internet censorship. The bill,which includes amendments to several current laws,still needs ...
Tags: Russia, Tech companies, bill, State Duma
The International Court of Arbitration, International Chamber of Commerce (ICC), has issued its arbitral award in the arbitration filed by R-Tech Ueno, together with Sucampo Pharmaceuticals and Sucampo, against Takeda Pharmaceutical ...
Tags: arbitration, amitiza capsule, business
GlaxoSmithKline (GSK) will pay $3bn, which includes a $1bn criminal fine and forfeiture and $2bn to resolve civil claims, in fine and will plead guilty for promoting antidepressants Paxil and Wellbutrin for unapproved uses. The largest ...
Tags: antidepressant, criminal fine, civil claim, health care fraud
Procedure for treating chronic atrial fibrillation,a condition that causes palpitations and fainting,features a laser balloon catheter. Green light for laser heart treatment? A follow-up study of 56 patients with chronic atrial ...
Tags: Heart Surgery, Laser, EAS
Europe, the US, Japan and China are racing to develop the next generation of supercomputer – exascale machines - capable of a million trillion calculations a second by 2020. But why do we need computers as fast as powerful as this? ...
Tags: supercomputer, exascale machines, exascale computers, exascale computing
Hospira has recalled 9 lots of cancer drugs including carboplatin, cytarabine, paclitaxel, and methotrexate packaged in vials in the US. The recall, which is based on the appearance of visible particles embedded in the glass located at ...
Tags: Recall, Cancer Drug, FDA
Mylan Pharmaceuticals, the Canadian subsidiary of Mylan, has gained Health Canada approval for Mylan-Bosentan Tablets, 62.5mg and 125mg. The generic version of Actelion's Tracleer is indicated for pulmonary arterial hypertension. Mylan ...
Tags: mylan-bosentan tablet, approval, pharmaceutical product
Medivation and Astellas Pharma have announced the submission of new drug application (NDA) for enzalutamide (formerly MDV3100) to the FDA. The enzalutamide has been studied in patients with castration-resistant prostate cancer who ...
Tags: enzalutamide, new drug application, pharmaceutical product